Fistula

A meta-analysis revealed no significant difference in primary study outcomes using Ellipsys or WavelinQ to create arteriovenous fistulas in patients requiring access for dialysis.

Patients with a higher degree of frailty are more likely to experience a longer wait time for fistula and graft functional use after dialysis initiation, according to data published in the American Journal of Kidney Diseases.

The arteriovenous fistula remains the “gold standard” in vascular access placement for patients on hemodialysis, clinicians said in interviews with Nephrology News & Issues.

Due to successful and durable access for hemodialysis through 5 years, percutaneous fistulas can be an alternative to surgery for access creation in patients with end-stage kidney disease, according to a speaker at ASN Kidney Week.

Adding surgical closure to anti-tumor necrosis factor therapy in perianal fistula demonstrates more successful and frequent healing with lower long-term perianal disease activity index, according to a presenter at UEG Week Virtual.

Study findings indicated that although most patients who had insurance before developing end-stage renal disease initiate hemodialysis with a central venous catheter, use of fistula for vascular access demonstrated the lowest risk for subsequent bloodstream infections.

The radiocephalic fistula yielded the best post-intervention primary patency rates when compared to brachiocephalic fistula and brachiobasilic fistula, according to study results reported in Kidney Medicine.